Primary tumors and metastases have been thought to initiate avascularly as multicellular aggregates and later induce angiogenesis or initiate vascularly by co-opting pre-existing host blood vessels without inducing angiogenesis. These two distinct concepts of microtumor vascularization have raised significant controversies. To clarify intratumoral vascularization and tumor cell behaviors at single-cell level during the earliest stage of microtumor initiation, we established primary and metastatic microtumor models in Tg(flk1:EGFP) transgenic zebrafish. We found that tumor cells preferred to initiate avascularly as multicellular aggregates and only later (50-100 cells in size) induced angiogenesis in blood-supply-sufficient microenvironments. In blood-supplydeficient microenvironments, less tumor cells (20-30 cells per fish) managed to co-opt and migrate along host vessels, whereas more tumor cells (100-300 cells per fish) could immediately induce angiogenesis without obvious cell migration. In a metastatic model, we clearly observed that tumor cells co-opted, migrated along and proliferated on the surface of host vessels at an early stage after they extravasated from host vessels and induced angiogenesis later when micromatastases comprised only 15-30 tumor cells. Moreover, the inducement of neovessels accelerated the growth of micromatastases in size, meanwhile, decreased the migration of tumor cells on the surface of host vessels. These results suggest that vessel co-option and angiogenesis have distinct contributions during the initiation of microtumors. Microtumors initiated reasonably through co-opting host vessels or inducing angiogenesis, depending on the differences of local microenvironments and cell numbers in microtumors. The results in this study may have important implications for the therapeutic application of antiangiogenic strategies.
Introduction
Primary microtumors and micrometastases are the initial stages of primary tumor and distal metastases, respectively. Tumor-induced angiogenesis and tumor cell vessel interactions are one of the most important events during these stages. However, the smallest microtumors and micrometastatic clones are very difficult to detect in cancer patients and traditional animal models (1, 2) . Most of our understanding of the initial formation of microtumors is deduced from static images captured from late stage tumors, in spite of the profound improvements in animal models and technologies for cancer research, e.g. skinfold chamber and intravital microscopy (3) (4) (5) . It is still currently not fully understood what exactly happens before and when tumor cells are primed to initiate vascularization at the earliest stage of microtumor formation, especially in micrometastases.
It has been generally accepted that the primary tumors and metastases initiate avascularly, then induce angiogenesis to support the exponential growth when the tumor mass is .1 mm (6,7). During past 10 years, this classic concept has been challenged by some studies that microtumors may initiate growth by exploiting pre-existent vessels, a process known as vascular co-option, without inducing angiogenesis in a vascularized tissue (8) (9) (10) (11) (12) (13) . However, the vascularization model of co-opting host vessel also was challenged by observations that support microtumor initiation through inducing angiogenic sprouts from host vessels (14) . These two distinct concepts of early tumor progression raised significant controversies, not only from a mechanistic point of view but also with regard to potential therapeutic implications (14) .
To establish a novel experimental system to directly and precisely assess the vascularization and tumor cells behaviors in microtumors, in the present study, we have established primary and metastatic microtumor models in Tg(flk1: EGFP) transgenic zebrafish in which microtumors originate from tens of (even an individual) tumor cells. Using cancer models in zebrafish has some obvious advantages: first, zebrafish has optically clear embryos which permitting high-resolution in vivo imaging (12, (15) (16) (17) (18) . Second, the zebrafish and human genomes exhibit remarkable sequence and functional conservation in cell cycle proteins, tumor suppressor, protooncogenes and angiogenic factors (19) (20) (21) . Therefore, zebrafish has been regarded as a promising alternative vertebrate model for cancer research. Various mammal xenografts have been established to investigate tumor cells survival, proliferation, tumoral angiogenesis and migration in living zebrafish embryo or larvae (21) (22) (23) (24) (25) . Using this novel experimental system, we clearly characterized the initial formation of primary microtumors and micrometastases, including tumor cell behaviors and intratumoral vascularization. We found cell numbers were more important than local microenviroments for the vascularization pattern in microtumors, through co-opting host vessels or inducing angiogenesis, at the earliest stage of microtumor initiation. Furthermore, our results showed that vessel co-option and angiogenesis have distinct contributions during the initiation process of microtumors and micrometastases.
Materials and methods

Cell culture
Mouse melanoma B16 cells and highly metastatic B16F10 cells, mouse colon carcinoma CT26 cells, mouse mammary gland tumor 4T1 cells, human breast adenocarcinoma MCF7 cells and highly metastatic human breast cancer MDA-MB-231 cells were cultured at 37°C in 5% CO 2 in RPMI-1640 medium supplemented with 10% fetal bovine serum. Red fluorescent cells were obtained either by RFP stable transfection (B16, CT26, 4T1) or CM-Dil staining (B16F10, MCF7, MDA-231). The stable transfection was generated with pCMV-DsRed-express (Clontech, Mountain View, CA) by using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA), followed by G418 selection. Briefly, 48 h after the transfection, tumor cells were harvested with trypsin and subcultured at a ratio of 1:15 into selective medium, which contained 800 lg/ ml G418. For CM-Dil labeling, cells were incubated with cell tracker CM-Dil (Invitrogen) at 37°C for 30 min and then washed with phosphate-buffered saline twice and checked under a fluorescence microscope (Axiovert 200; Carl Zeiss Microimaging, Thornwood, NY).
Zebrafish husbandry and cell microinjection
The Tg(flk1:EGFP) transgenic zebrafish line with the endothelial-specific flk1 promoter directing the expression enhanced green fluorescent protein (EGFP) was used (26, 27) . Zebrafish were bred and maintained normally (temperature, 28°C; pH 7.2-7.4; 14 h on and 10 h off light cycle). Red fluorescence-labeled cells were harvested at a concentration of 1-5 Â 10 a Flaming/Brown micropipette puller (PN-30; Narishige, Tokyo, Japan). Dechorionated embryos at 48 hours postfertilization were anesthetized with 0.04 mg/ml tricaine (Sigma St Louis, MO) and injected with 20-300 cells per embryo suspended in 5-15 nl phosphate-buffered saline (PBS) using an electronically regulated air pressure microinjector (PL1-90; Harvard Apparatus, Holliston, MA). To transplant tumor cells on the pericardial membrane, tumor cells were directly injected into the pericardial cavity. Sixteen hours later, the embryos with tumor aggregate attaching to the pericardial membrane were picked out under fluorescent microscope. For cell transplantation in the fish tissue, tumor cells were suspended at a higher concentration (1 Â 10 8 cells/ml) and injected with a much smaller volume ($1 nl). After injection, zebrafish were washed once with fish water and examined for the presence of fluorescent cells. For every kind of cell implantation, $50 fish were selected and maintained in fresh fish water with 0.003% 1-phenyl-2-thiourea and subsequently documented photographically. Fish water was changed daily, and larva .5 days old were fed twice a day with baby fish food and maintained under normal fish husbandry conditions. For pharmacological tests, SU5416 (Sigma) was added directly to the fish water at a final 2.5lM concentration. dimethyl sulfoxide (Sigma) was used as a control.
Microangiography Forty-eight hours old zebrafish embryo were anesthetized by 0.04 mg/ml tricaine. Dextran-Texas Red in PBS (5 mg/ml, molecular mass, 70000 Da; Molecular Probes, Eugene, OR) was microinjected into the embryo circulation from the perivitelline space as described above. Injected fish embryos were washed once and then monitored under a fluorescence microscope within 5 min.
Tumor cell counting Tumor masses were isolated from zebrafish using anatomy needle under Zeiss Stemi 2000-C dissecting microscope (Carl Zeiss Microimaging). Then tumor tissues were treated with collagenase I and II at 37°C for 20 min. After being washed with PBS two times and stained with Hochest33342 (Sigma), tumor cells were counted under fluorescence microscope (Axiovert 200; Carl Zeiss Microimaging).
In vitro invasion assay An in vitro invasion assay was carried out to examine tumor migration according to the serum concentration gradient. In briefly, 24-well transwell units with 8 lm polycarbonate Nucleopore filters (Corning, lowell, MA) were coated with 30 ll of a 1:2 mixture of Matrigel:PBS at room temperature for 1 h. Red B16 cells (2 Â 10 5 ) suspended in RPMI-1640 medium supplemented with 0, 5 or 10% fetal bovine serum were placed in the upper compartments, respectively. The lower chambers were filled with RPMI-1640 medium with 10% fetal bovine serum. The transwell plates were incubated at 37°C for 48 h. Cells migrating to the lower surface of the membrane were counterstained with Hoechst 33342. Five random fields were counted under fluorescence microscope.
Fluorescent optical imaging
Living zebrafish embryos were anesthetized by 0.04 mg/ml tricaine and embedded in a dorsal, ventral, or lateral orientation in 3% methylcellulose. Digital micrographs were taken with a Zeiss Imager.Z1 fluorescence microscope (Carl Zeiss Microimaging) equipped with an AxioCam MRc5 digital CCD camera (Carl Zeiss Microimaging). Whole animal images were taken with a Zeiss Stemi 2000-C stereo microscope with the AxioCam MRc5 digital CCD camera (Carl Zeiss Microimaging). All images were taken in the same focal plane in brightfield and transmitted light passing through RFP or GFP filters, with Axiovision rel.4.8 software.
Statistical analysis
Data was assayed by unpaired Student's t-test. A level of P , 0.05 was regarded as statistically significant.
Results
Vascularization through angiogenesis in microtumors established in blood-supply-sufficient microenvironment
The immune system of zebrafish is not mature until 2 weeks postfertilization (28), so human or mouse tumor cells can survive, migrate and proliferate in zebrafish larvae. Green fluorescence images and microangiography in Tg(flk1: EGFP) transgenic zebrafish revealed that vascular capillaries and blood supply are abundant within the perivitelline space, whereas scarce on pericardial membrane (Figure 1A) , which provides us opportunities to dynamically observe the initial vascularization and cell behaviors in microtumors established in distinct vascular microenvironments.
We first microinjected red fluorescence-labeled melanoma B16 cells (20-30 cells per fish) into the perivitelline space at 48 hours postfertilization Tg(flk1: EGFP) zebrafish larvae. Tumor cells were spherical and loosely scattered in the perivitelline space immediately after the injection ( Figure 1B , t 0 panel), and began to aggregate locally within one day ( Figure 1B , t 0 þ 1d panel). Three days after cell injection, neoangiogenic sprouts within tumors were firstly detected from the pre-existing host-dilated vessels ( Figure 1B , t 0 þ 3d panel; dilated vessels indicated by arrow). By isolating tumor mass and counting cell numbers under microscope ( Figure 1D ), we knew angiogenesis could be induced by less as 50-100 tumor cells. By the sixth day post injection (d.p.i.), an obvious tumor mass was observed in zebrafish ( Figure 1C ; tumor indicated by arrows), in which filled with a chaotic plexus of newly formed angiogenic sprouts ( Figure 1B , t 0 þ 6d panel; neovessels indicated by arrows). When angiogenic sprouts were blocked by SU5416, the specific VEGFR2 inhibitor without cytotoxic effect to B16 cells, the growth of tumor also was inhibited significantly ( Figure 1E ). Quantification analysis further showed the important role of angiogenesis to the growth of microtumors ( Figure 1F) .
Similarly, tumor growth and angiogenesis in the perivitelline space in Tg(flk1: EGFP) zebrafish were confirmed in more mouse and human tumors, including mouse highly metastatic melanoma B16F10 cells, mouse colon carcinoma CT26 cells, mouse mammary gland tumor 4T1 cells and human breast adenocarcinoma MCF7 cells (supplementary Figure 1A is available at Carcinogenesis Online). The results showed that all tumors were established in situ with similar developmental pattern within 5 days, but tumor growth and angiogenesis potential were different for different tumor types (supplementary Figure 1B and C is available at Carcinogenesis Online).
Less tumor cells initially co-opt pre-existing host vessel in bloodsupply-deficient microenvironment
To investigate the initiation of tumor vascularization in a blood-supply-deficient microenvironment, we implanted 20-30 tumor cells per fish onto the inner surface of pericardial membrane. Similar to those cells in the perivitelline space, spherical and loosely scattered tumor cells on pericardial membrane also aggregated at the next day ( Figure   Fig Angiogenesis and vascular co-option 2A; t 0 panel). To our surprise, these tumor cells did not proliferate locally as expected but initiated migration toward and co-opt host ventral aorta (Figure 2A ). Within the following 6 days, they kept longitudinal migration along the front aorta at the speed of 11 ± 3.4 lm/day ( Figure 2B ). During this process, there only was a limited amount of cell proliferation in the primary site and no obvious tumorinduced angiogenesis was observed ( Figure 2A) . Next, to evaluate the differences in migration along host vessels between tumor cells with different metastatic capability, we injected two pairs of tumor cells onto the inner surface of pericardial membrane as described previously, including B16 versus highly metastatic B16F10 and MCF7 versus highly metastatic MDA-231. The results showed that highly metastatic B16F10 and MDA-231possessed higher migration velocities than B16 and MCF7 ( Figure 2D-G) . By the third d.p.i., the migration of B16F10 had reached the end of zebrafish hypobranchial arteryhpi (140 ± 21 lm); however, B16 cells only migrated 52 ± 8 lm away from the primary sites (the migration was measured and calculated with the ZEISS Axiovision rel.4.8 software) ( Figure 2D and E). Similarly, highly metastatic human MDA-231 cells also migrated faster significantly than the coupled cells of MCF7 (poorly metastatic) ( Figure 2F and G).
More tumor cells immediately induce angiogenesis in blood-supplydeficient microenvironment
It has been widely accepted that enough tumor cells (10 5 $10 6 cells (7) or 100$300 cells (4) or 50-100 cells as our observations) are critical to endow microtumors to induce angiogenesis. We have found that a number of tumor cells below the thresholds of inducing angiogenesis prefer to co-opt and migrate along pre-existing host vessel in blood-supply-deficient microenvironment (Figure 2 ). This attracted us to ask if more tumor cells, surpassing the threshold of inducing angiogenesis, would co-opt and migrate along host vessel or induce angiogenesis in the blood-supply-deficient microenvironment. To answer this question, we implanted 200-300 red B16 cells into zebrafish pericardium (Figure 3A and B; top panel) . Angiogenesis was obviously observed in the region closest to host aortas on the third day after implantation (Figure 3A , top t 0 þ 3d panel). Cell migration along host vessels was not obvious when large cell clusters were transplanted ( Figure 3A and B, top panel), which was in strong contrast to the significant migration behaviors when few cells (20-30 cells) were microinjected at this place (Figure 3A and B; bottom  panel) . Whereas, tumor cells located far away from host vessels exhibited obvious migrating away from tumor mass, and no angiogenesis was observed at this region ( Figure 3B; top panel) . The Quantification analysis further confirmed the significant difference in cell migration when different numbers of cell were implanted onto the inner surface of pericardial membrane ( Figure 3C ). When highly metastatic melanoma B16F10 cells (100-200 cells and 20-30 cells) were into zebrafish pericardium (Figure 3D ), the migration of highly metastatic B16F10 was more obvious and faster than B16-red cells ( Figure 3D-F) . Obvious angiogenesis also was induced ( Figure 3D and E, t 0 þ 3d, top panel) by 100-200 tumor cells, and the cell migration along host vessels was delayed ( Figure 3F ). circulation. At 24 h after injection, .70% of tumor cells (78 ± 7%) were able to complete the extravasation process. On the third day after cell injection, about half of tumor cells had survived apoptotic stresses from host microenviroment (55 ± 9% of injected cells) and proliferated in new sites in zebrafish ( Figure 4A and B). Although metastatic microclones could be observed at other sites, most of them were established at the tail of zebrafish (62 ± 16% of micrometastases) ( Figure 4A and B). Extravasated tumor cells, whatever the sites in zebrafish, always tended to closely associated with the host vessel ( Figure 4B-D) . Especially for cells in zebrafish brain, some extravasated tumor cells perfectly wrapped up the pre-existing host vessels with the capillary-like pseudopodiums ( Figure 4D ). Next, we studied the vascularization of one micrometastase established in the tail of zebrafish over time. This micrometastase originated from the tumor cell that resided in posterior caudal vein after the cell injection ( Figure 4E, t 0 panel) . Two days after injection, tumor cells were outside of vasculature but closely interacted with host vessels ( Figure 4E, t 0 þ 1d panel) . Three days post microinjection, the first angiogenic sprout within the micrometastase began to be detected ( Figure 4E , t 0 þ 3d panel; neovessel was indicated by arrow). Through counting the cell number under microscope as described above, we knew the smallest micrometastase that had induced first angiogenic sprout could be one that comprised only 15 tumor cells. From our known, this was the fewest cells that could induce angiogenesis, which was far fewer than that in primary microtumors in zebrafish (50-100 cells). At the fifth day, with the development of metastatic microclone, the angiogenic sprout also progressed ( Figure  4E , t 0 þ5d panel). On day 8, more angiogenic sprouts were induced with the progression of micrometastassis ( Figure 4E , t 0 þ 8d panel).
Vessel co-option, cell migration and intratumoral angiogenesis during the formation of micrometastases
In order to investigate the characteristics and contributions of vascularization through co-opting host vessels or inducing angiogenesis to the initiation of micrometastases, the expansion of a metastatic microclone was traced continuously and analyzed quantitatively ( Figure 5A-D) . During the first 3 days, extravasated tumor cells proliferated longitudinally along zebrafish vessels ( Figure 5A , t 0 and t 0 þ 3d panels). From fourth to seventh d.p.i., the expansion of micrometastases was still significantly longitudinal along pre-existing vessels, whereas the growth in transverse direction was relative slower ( Figure 5A , t 0 þ 5d and t 0 þ 7d panels). Neovasculatures began to be induced from pre-existing host vessels at the third day and function well (blood flow was observed) at fifth d.p.i. (Figure 5A , t 0 þ 5d panel). Interestingly, when more functional neovasculatures were induced in the tumor tissue, the growth speed in longitudinal direction markedly slowed down, whereas the expansion in transverse direction became obvious ( Figure 5A , t 0 þ 7d and t 0 þ 10d panels). Quantitative analysis showed that significant tumor growth initiated only after the process of tumor neovascularization had been induced. Moreover, the increase of vessel density in microtumor significantly accelerated the growth in transverse direction; however, decreased the growth in longitudinal direction ( Figure 5C and D) .
Blood components attract the tumor Cells migrating toward host vessels
We next microinjected isolated cells into zebrafish tissues to characterize the migration behaviors at single-cell level and to explore potential mechanisms underlying metastatic cell migration in vivo (Figure 6A-D) . Time-lapse imaging revealed that the implanted single tumor cell exhibited a chemotaxis-like migration pattern. They expanded pseudopodium toward and migrated to the nearest intersegmental vessel (ISV) at 12 hours post cell injection (h.p.i.). At 36 h.p.i., the ISV was closely co-opted by the tumor cell ( Figure 6A and B) . To further validate functions of blood components in host vessels on attracting tumor cells, we artificially made a microenvironment with the microinjecting needle, in which an ISV was damaged to prevent blood flow, whereas the dorsal longitudinal anastomotic vessel was left intact. Then, two B16-RFP cells were microinjected into the tissue near the damaged ISV. During the following 3 days, these two tumor cells migrated away from the damaged ISV, but toward dorsal longitudinal anastomotic vessel ( Figure 6C and D) , strongly suggesting that Angiogenesis and vascular co-option the migration of tumor cells toward host vessels resulted from the attraction of blood components. The result of invasion assay in vitro also supported this point of issue ( Figure 6E-F) .
Discussion
The concept of tumor vascularization, tumors initiate as avascular cell aggregates and later stimulate angiogenesis when tumor size progresses to a few hundred micrometers to 1 mm in diameter ($10 5 to 10 6 cells), has been widely accepted. About 10 years ago, this classic model began to be challenged by some studies that tumors initially grow by co-opting pre-existing host vessels and later induce angiogenesis when they have reached a size of several millimeters in diameter. One of the most reasonable explanations to these two different models is the discrepancy of vascular microenvironments in applied experimental models. Namely, microtumor initiates avascularly among avascular spaces, while grow vascularly by co-opting pre-existing host vessels. However, the initiation pattern of co-opting host vessel was challenged by the observations that multicellular spheroids ($0.005 mm 3 ) initiate vascular growth by angiogenic sprouting via the simultaneous expression of VEGFR2 and Ang-2 by host and tumor endothelium and that host blood vessels are not co-opted by tumor cells but rather are used as trails for tumor cell invasion to the adjacent host tissue (14) . However, the multicellular spheroids of $0.005 mm 3 in size used in these studies have comprised $5000 tumor cells, which have been potent to induce neoangiogenesis from host vessels, based on previously reported study (4) . Therefore, it has told us little about the events that occured in smaller microtumors or even single cell. Furthermore, this will result in the neglect to the vascular co-option, if the co-option occurs earlier than neoangiogenesis during the process of microtumor initiation.
To investigate the vascularization and tumor cell behaviors at the earliest stage of microtumors initiation, we have established an experimental system in zebrafish by implanting red tumor cells into Tg(flk1: EGFP) transgenic zebrafish. The sharp visual contrast between red tumor cells and green vascular endothelial cells in transparent zebrafish provides unprecedented clarity, allowing the simultaneous observation of vascularization and tumor cells behaviors within microtumors at single-cell level and without surgical operation on the animals (22) (23) (24) . Moreover, the microinjection technology allows implanting 20-30 tumor cells and provides us opportunity to investigate smaller microtumors than previously have reported. So, the tumor xenograft model in zebrafish is especially appropriate to mimic the initial stages of tumor angiogenesis and metastasis. It should be pointed out that the cell-injected zebrafish embryos are not maintained at 37°C, the optical temperature for mammalian cell growth and metabolism. However, many other studies have shown that mammary tumor cells can survival, migrate, proliferate, metastasis and induce angiogenesis in zebrafish (18, (21) (22) (23) (24) , which is similar to the results obtained from other mammary models or experimental systems in vitro at 37°C. In addition, there are some anatomic differences between the zebrafish and mammalians, whereas the basic vascular developing plan in zebrafish are strong similar to that in mammalians (29) .
In the present study, to explore the relationship between local microenvironment and tumor vascularization pattern, we identified two sites for cell implantation in zebrafish: perivitelline space (with blood supply) and pericardial membrane (without blood supply) ( Figure  1A ). We found tumor cells that were implanted into perivitelline space progressed as described in the classical neovascularization model, namely, initiated as avascular emboli in situ and then began to induce significant angiogenesis. Interestingly, we found the threshold of inducing neovessels was 50-100 cells in size, which was much earlier not only than the prevailing view point ($10 5 to 10 6 cells) but than the report that angiogenesis began to be induced by less as 100-300 cells (4) . Although this discrepancy may result from the differences on experimental systems, i.e. different tumor cells, different hosts (mouse versus zebrafish), it is more probably that the higher resolution observations in our experimental system are more sensitive to reliably identify the initial tumoral angiogenic sprout that originates from pre-existing host vessels. From our knowledge, at least, this is the earliest stage that has been reported that microtumors possess the capability to induce neoangiogenesis. This discovery strongly indicates that the angiogenesis in tumor occurs much earlier than we previously thought. Antiangiogenic therapy may be more effective if it is applied at the earliest stage of tumor development. Consequently, it provides a more reasonable explanation to the phenomenon that microtumors fail to initiate when antiangiogenic treatment is started on the day of implantation (4, 14, 30, 31) .
The critical role of VEGF/VEGFR-2 pathway during the initial vascular formation of microtumor growth has been widely accepted. It is also indispensable to the inducement of neoangiogenesis in our experimental system. The significant upregulation of VEGF in hypoxia tumor cells has been considered the hallmark of the 'angiogenic switch' during tumor progression. However, in our present study, neovessels began to be induced by tiny cellular aggregates of less as 50-100 cells in size or be induced by metastatic microclones comprising only 15-30 cells. From the conceptual point of view, tumor cells in this kind of cell spheroids would not become hypoxic (14) , to say nothing of the microtumors growing in a blood-supply-sufficient local microenvironment in zebrafish. However, we and many other studies have reported that B16 cells and other, a variety of tumor cells can continuously product express more or less VEGF in vitro and in vivo under normoxic conditions, especially when formed as multicellular aggregates (14, (32) (33) (34) (35) . Therefore, it is reasonable that neoangiogenesis was detected to be induced by tens of tumor cells in our high-resolution experimental system. Metastatic tumor cells have been reported to have a more potent ability to triggering angiogenesis (14) ; here, we actually found neoangiogenesis began to be induced by less tumor cells in micrometastase (15-30 cells) than in primary microtumors (50-100 cells).
When 20-30 tumor cells were implanted into pericardium, a place lacking pre-existing host vasculature and blood supply in zebrafish, tumor cells did not initiate in situ as an avascular aggregate but closely coopted and migrated along pre-existing host vasculature and the migration velocity was highly related to the metastatic potentials of tumor cells. During this process, we have not observed the inducement of angiogenesis. However, when 200-300 cells were implanted into pericardium, obvious tumor neoangiogenesis was induced immediately and no significant migration was observed. These interesting results indicated that: firstly, local microenvironment is important to determine the vascularization pattern during microtumor initiation. Secondly, cell number, endowing microtumors the ability of inducing angiogenesis, is a more critical parameter than local microenvironment to determine the vascularization pattern of microtumor. Furthermore, we can deduce that: firstly, to initiate exponential growth tumors must depend on vascularization through angiogenesis, which is indispensable and more powerful than vessel co-option for tumor mass to acquire nutrition or oxygen from host circulation system. If possible, tumors prefer to choose this kind of vascularization pattern. Secondly, the strategy of co-opting host vessels is an alternative choice for tumor cells to survive when they can not acquire enough support from microenvironments and have no capability to establish intrinsic vessels through inducing angiogenic sprouting from pre-existing host vessels. This is consistent with the observations that antiangiogenic therapies result in an increase in vascular co-option (35) (36) (37) (38) (39) . Thirdly, the co-option and migration along host vessels would be inhibited once angiogenic sprouts began to be induced, e.g. 200-300 cells that were implanted onto pericardium induced immediately obvious neoangiogenesis but no significant migration was observed. These hypotheses were further confirmed by the observations in our metastatic model. In the metastatic model, we clearly found extravasated tumor cells would immediately co-opt, migrate along and proliferate on the surface of host vessels after escaping from host vessels and only induced angiogenesis at later stages. Before and shortly after the inducement of neovasculature from pre-existing host vessels, the micrometastase mainly developed longitudinally along pre-existing vessels, meanwhile the growth in transverse direction was relative slower. However, when more functional neovasculatures existed in tumor tissue, the growth in longitudinal direction markedly slowed down, whereas the expansion in transverse direction became obvious. Meanwhile, the amplification of micromatastases in size also significantly accelerated during this time.
Many studies have reported the intimate association between host vessels and extravasated cells during tumor metastasis (4, 39) , which are consistent with our observations in metastatic model. We surprisingly found that some extravasated tumor cells in brain co-opted host vessels perfectly with dramatic vessel-like pseudopodia ( Figure 4D ). This co-opting manner makes them cover vessel surface area as much as possible and obtains more necessary support from host, such as nutrients or oxygen. Conversely, those tumor cells that failed to migrate to the surface of host vessels often died via apoptosis (data not shown). So, the intimate association between tumor cells and preexisting host vessels is critical for tumor cells to survive and further progress during metastasis. This is the first observation, to our knowledge, that tumor cells can perfectly co-opt pre-exist host vessels with dramatic vessel-like pseudopodia. Reasons that can well interpret this kind of behavior can be found in the book by Weinberg (40) : 'tumor cells require effective interactions with the vasculature in order to acquire nutrients and to shed metabolic waste products and carbon dioxide. . In some normal tissues with an especially high metabolic activity, most cells enjoy direct contact with at least one capillary. This intimate association means that their access to oxygen and critical nutrients not dependent on the diffusion of these molecules over large distances and through densely packed cell layers'.
Taken together, the vessel co-option and angiogenesis have distinct contributions at the earliest stage of microtumors initiation and metastasis. Angiogenesis plays the critical role in tumoral exponential Angiogenesis and vascular co-option growth, whereas the strategy of co-opting host vessels just is an alternative but essential choice for tumor cells to survive. During the process of antiangiogenic therapies, vascular co-option may represent an important mechanism by which tumor partly evade and resist to conventional antiangiogenic treatments. It is concluded that future antivascular therapies should be further developed based on the comprehensive considerations to the recent progresses in vascular research.
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